Tenderwize
Back to tender search

Drug Discount Agreements for Various Active Substances (Open-House)

AOK NordWest - Die Gesundheitskasse·Dortmund, Germany·Deadline Jun 24, 2027 · 310 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

Buyer retains right to award exclusive contracts later, which will suspend these open-house agreements. Typically 8-10...

No documented procurement documents analyzed; may contain additional obligations not covered in notice.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Supply of pharmaceutical products (discount agreements) for seven active substances: Budesonide (oral 4mg), Eltrombopag, Fluorouracil (cream), Mebeverine, Nilotinib, Rotigotine, Umeclidinium bromide.
  • Open-house model: any eligible pharmaceutical entrepreneur can join at any time during the contract period.
Show full summary

The tender is an open-house procedure for drug discount agreements (Rabattverträge) under §130a Abs. 8 SGB V for seven active substances: Budesonide (oral, 4mg), Eltrombopag, Fluorouracil (cream), Mebeverine, Nilotinib, Rotigotine, and Umeclidinium bromide. The buyer is AOK NordWest. The procedure is not a public procurement under EU directives (per EuGH C-410/14) but published voluntarily. The contract duration is up to 24 months starting 01.09.2025. All eligible pharmaceutical entrepreneurs can join at any time. No estimated value or award criteria are specified. Electronic submission is not allowed; applications are via email. The deadline for submission is 24.06.2027, 23:59 (but continuous accession is possible).

Risks

Buyer retains right to award exclusive contracts later, which will suspend these open-house agreements. Typically 8-10...

No documented procurement documents analyzed; may contain additional obligations not covered in notice.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG for the offered medicinal products, throughout the contract duration.
  • Application via email to [email protected].

Administrative

  • Uniform contract conditions; no individual negotiations.

Requirements may be incomplete.

Buyer

Location

Dortmund, DEU

Website

www.aok.de

Identifier

DE124159739

Activity

Health

Lots (1)

LOT-0001

Drug Discount Agreements for Various Active Substances (Open-House)

All eligible pharmaceutical entrepreneurs can conclude discount agreements for the listed active substances under uniform conditions. The contract runs max. 24 months from 01.09.2025. There is no exclusivity; the buyer may later award exclusive contracts that suspend these agreements.

SuppliesEU fundedElectronic submission

Location

Hagen, Germany

Duration

Aug 2025 - Aug 2027

Category

Pharmaceutical products

Deadline

Deadline Jun 24, 2027

Procurement Details

Publication date
17 Jul 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
470057-2025

Documents (1)

Similar tenders